• ホーム
  • 検索結果
  • Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.

Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.

Thrombosis and haemostasis (2015-01-09)
Hai Zhou, Yu Hou, Xuena Liu, Jihua Qiu, Qi Feng, Yawen Wang, Xu Zhang, Yanan Min, Linlin Shao, Xinguang Liu, Guosheng Li, Lizhen Li, Lei Yang, Shuqian Xu, Heyu Ni, Jun Peng, Ming Hou
要旨

Impaired megakaryocyte maturation and insufficient platelet production have been shown to participate in the pathogenesis of immune thrombocytopenia (ITP). Our previous study demonstrated that low expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in megakaryocytes contributed to impaired platelet production in ITP. Decitabine (DAC), a demethylating agent, is known to promote cell differentiation and maturation at low doses. However, whether decitabine is potential in promoting megakaryocyte maturation and platelet release in ITP is unclear. In this study, we evaluated the effect of DAC on megakaryocyte maturation and platelet release in the presence of ITP plasma that has been shown to cause impaired megakaryocyte maturation and platelet production. We observed that low-dose DAC (10 nM) could significantly increase the number of mature polyploid (≥ 4N) megakaryocytes in cultures with plasma from healthy controls and more than one-half of ITP patients in vitro. Furthermore, the number of platelets released from these megakaryocytes significantly increased compared with those untreated with DAC. In these megakaryocytes, DAC significantly enhanced TRAIL expression via decreasing its promoter methylation status. These findings demonstrate that low-dose DAC can promote megakaryocyte maturation and platelet production and enhance TRAIL expression in megakaryocytes in healthy controls and ITP. The potential therapeutic role of low-dose DAC may be beneficial for thrombocytopenic disorders.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ヨウ化プロピジウム, ≥94.0% (HPLC)
Sigma-Aldrich
ヨウ化プロピジウム 溶液, solution (1.0 mg/ml in water)
Sigma-Aldrich
フルオレセイン, for fluorescence, free acid
Sigma-Aldrich
インターロイキン-3 ヒト, IL-3, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Sigma-Aldrich
IL-3 ヒト, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Sigma-Aldrich
IL-3 ヒト, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
インターロイキン-3 ヒト, IL-3, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Sigma-Aldrich
α,α-Dicyanoethyl acetate, 98%